KRT18 and cancer: Among EPCAM-positive cells isolated through the GenoCTC platform, CTCs were identified by immunostaining with an anti-CK18 antibody directed towards a cancer epithelial cell marker and an anti-CD45 antibody recognizing a leukocyte marker (Figure 3B).